- €53.79m
- €171.49m
- €10.21m
- 17
- 73
- 37
- 35
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9.53 | 9.12 | 9.5 | 9.74 | 10.2 |
Cost of Revenue | |||||
Gross Profit | 6.66 | 7.34 | 7.66 | 7.96 | 8.15 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18.1 | 4.52 | 15.3 | 2.15 | 13.6 |
Operating Profit | -8.55 | 4.6 | -5.79 | 7.59 | -3.36 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.4 | 3.16 | -7.17 | 5.6 | -3.58 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.4 | 3.16 | -7.17 | 5.6 | -3.58 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -10.4 | 3.16 | -7.17 | 5.6 | -3.58 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.4 | 3.16 | -7.17 | 5.6 | -3.58 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.78 | 1.45 | -3.29 | 2.57 | -1.57 |
Dividends per Share |